MacFarlan Smith

Pharmaceutical company based in Edinburgh, Scotland

Macfarlan Smith is a pharmaceutical company based in Edinburgh, Scotland. It is a subsidiary of Johnson Matthey, a British multinational speciality chemicals and sustainable technologies company. Macfarlan Smith is renowned for its production of alkaloids and other active pharmaceutical ingredients (APIs), particularly those used in pain management and addiction treatment.

History

Macfarlan Smith traces its origins back to 1815 when it was founded by William Flockhart, a chemist and druggist in Edinburgh. The company initially focused on the production of morphine and other opium derivatives, which were in high demand for their analgesic properties. Over the years, Macfarlan Smith expanded its product range and expertise in the field of alkaloid extraction and purification.

In the 20th century, the company became a key supplier of codeine and other opiates to the pharmaceutical industry. Its expertise in handling controlled substances and its commitment to quality made it a trusted partner for pharmaceutical companies worldwide.

In 2001, Macfarlan Smith was acquired by Johnson Matthey, which allowed it to further expand its capabilities and reach in the global pharmaceutical market.

Operations

Macfarlan Smith operates a state-of-the-art manufacturing facility in Edinburgh, where it produces a wide range of APIs. The company is particularly known for its expertise in the production of controlled substances, including opioids and cannabinoids.

The company's operations are supported by a strong focus on research and development, ensuring that it remains at the forefront of pharmaceutical innovation. Macfarlan Smith collaborates with academic institutions and industry partners to develop new products and improve existing processes.

Products

Macfarlan Smith's product portfolio includes a variety of APIs used in pain management, addiction treatment, and other therapeutic areas. Some of the key products include:

• Morphine
• Codeine
• Oxycodone
• Buprenorphine
• Methadone
• Cannabidiol (CBD)

These products are supplied to pharmaceutical companies around the world, where they are formulated into finished dosage forms for patient use.

Sustainability and Ethics

As part of Johnson Matthey, Macfarlan Smith is committed to sustainability and ethical business practices. The company adheres to strict environmental and safety standards in its operations and is dedicated to reducing its carbon footprint.

Macfarlan Smith also places a strong emphasis on ethical sourcing and the responsible use of controlled substances. It works closely with regulatory authorities to ensure compliance with all relevant laws and regulations.

Related pages

• Johnson Matthey
• Pharmaceutical industry
• Opioid
• Cannabinoid

Gallery

File:Johnson Matthey Macfarlan Smith.png

Johnson Matthey Macfarlan Smith logo